Articles producció científica> Infermeria

Influence of Maternal Diabetes on the Risk of Neurodevelopmental Disorders in Offspring in the Prenatal and Postnatal Periods

  • Identification data

    Identifier: imarina:9290735
    Authors:
    Perea, VeronicaUrquizu, XavierValverde, MaiteMacias, MarinaCarmona, AnnaEsteve, EstherEscribano, GemmaPons, NuriaGimenez, OriolGirones, TeresaSimo-Servat, AndreuDomenech, AndreaAlonso-Carril, NuriaQuiros, CarmeAmor, Antonio J.Lopez, EvaJose Barahona, Maria
    Abstract:
    Background: This study aimed to evaluate the influence of maternal diabetes in the risk of neurodevelopmental disorders in off-spring in the prenatal and postnatal periods.Methods: This cohort study included singleton gestational diabetes mellitus (GDM) pregnancies >22 weeks' gestation with live newborns between 1991 and 2008. The control group was randomly selected and matched (1:2) for maternal age, weeks of gesta-tion and birth year. Cox regression models estimated the effect of GDM on the risk of attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and maternal type 2 diabetes mellitus (T2DM). Moreover, interaction between ma-ternal T2DM and GDM-ADHD relationship was evaluated.Results: Children (n= 3,123) were included (1,073 GDM; 2,050 control group). The median follow-up was 18.2 years (interquar-tile range, 14.2 to 22.3) (n= 323 with ADHD, n= 36 with ASD, and n= 275 from women who developed T2DM). GDM exposure was associated with ADHD (hazard ratio [HR]crude, 1.67; 95% confidence interval [CI], 1.33 to 2.07) (HRadjusted, 1.64; 95% CI, 1.31 to 2.05). This association remained significant regardless of the treatment (diet or insulin) and diagnosis after 26 weeks of gesta-tion. Children of mothers who developed T2DM presented higher rates of ADHD (14.2 vs. 10%, P= 0.029). However, no interac-tion was found when T2DM was included in the GDM and ADHD models (P> 0.05). GDM was not associated with an increased risk of ASD (HRadjusted, 1.46; 95% CI, 0.74 to 2.84).Conclusion: Prenatal exposure to GDM increases the risk of ADHD in offspring, regardless of GDM treatment complexity. How-ever, postnatal exposure to maternal T2DM was not related to the development of ADHD.
  • Others:

    Author, as appears in the article.: Perea, Veronica; Urquizu, Xavier; Valverde, Maite; Macias, Marina; Carmona, Anna; Esteve, Esther; Escribano, Gemma; Pons, Nuria; Gimenez, Oriol; Girones, Teresa; Simo-Servat, Andreu; Domenech, Andrea; Alonso-Carril, Nuria; Quiros, Carme; Amor, Antonio J.; Lopez, Eva; Jose Barahona, Maria;
    Department: Infermeria
    URV's Author/s: Alonso Carril, Núria
    Keywords: Women Type 2 Reduction Neurodevelopmental disorders Metformin Mellitus Intervention Insulin Gestational Diagnosis Diabetes mellitus Diabetes Association
    Abstract: Background: This study aimed to evaluate the influence of maternal diabetes in the risk of neurodevelopmental disorders in off-spring in the prenatal and postnatal periods.Methods: This cohort study included singleton gestational diabetes mellitus (GDM) pregnancies >22 weeks' gestation with live newborns between 1991 and 2008. The control group was randomly selected and matched (1:2) for maternal age, weeks of gesta-tion and birth year. Cox regression models estimated the effect of GDM on the risk of attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and maternal type 2 diabetes mellitus (T2DM). Moreover, interaction between ma-ternal T2DM and GDM-ADHD relationship was evaluated.Results: Children (n= 3,123) were included (1,073 GDM; 2,050 control group). The median follow-up was 18.2 years (interquar-tile range, 14.2 to 22.3) (n= 323 with ADHD, n= 36 with ASD, and n= 275 from women who developed T2DM). GDM exposure was associated with ADHD (hazard ratio [HR]crude, 1.67; 95% confidence interval [CI], 1.33 to 2.07) (HRadjusted, 1.64; 95% CI, 1.31 to 2.05). This association remained significant regardless of the treatment (diet or insulin) and diagnosis after 26 weeks of gesta-tion. Children of mothers who developed T2DM presented higher rates of ADHD (14.2 vs. 10%, P= 0.029). However, no interac-tion was found when T2DM was included in the GDM and ADHD models (P> 0.05). GDM was not associated with an increased risk of ASD (HRadjusted, 1.46; 95% CI, 0.74 to 2.84).Conclusion: Prenatal exposure to GDM increases the risk of ADHD in offspring, regardless of GDM treatment complexity. How-ever, postnatal exposure to maternal T2DM was not related to the development of ADHD.
    Thematic Areas: Endocrinology, diabetes and metabolism Endocrinology & metabolism
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    Author's mail: nuria.alonso@estudiants.urv.cat
    Author identifier: 0000-0002-5846-0988
    Record's date: 2024-09-07
    Papper version: info:eu-repo/semantics/publishedVersion
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Papper original source: Diabetes & Metabolism Journal. 46 (6): 912-922
    APA: Perea, Veronica; Urquizu, Xavier; Valverde, Maite; Macias, Marina; Carmona, Anna; Esteve, Esther; Escribano, Gemma; Pons, Nuria; Gimenez, Oriol; Giron (2022). Influence of Maternal Diabetes on the Risk of Neurodevelopmental Disorders in Offspring in the Prenatal and Postnatal Periods. Diabetes & Metabolism Journal, 46(6), 912-922. DOI: 10.4093/dmj.2021.0340
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2022
    Publication Type: Journal Publications
  • Keywords:

    Endocrinology & Metabolism,Endocrinology, Diabetes and Metabolism
    Women
    Type 2
    Reduction
    Neurodevelopmental disorders
    Metformin
    Mellitus
    Intervention
    Insulin
    Gestational
    Diagnosis
    Diabetes mellitus
    Diabetes
    Association
    Endocrinology, diabetes and metabolism
    Endocrinology & metabolism
  • Documents:

  • Cerca a google

    Search to google scholar